Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate L Seib

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|July 15, 2017
Gonorrhoea vaccines: a step in the right directionKate L Seib
Sexually Transmitted Infections|April 3, 2016
Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccineEvgeny A Semchenko, Kate L Seib
Nature Reviews. Urology|October 30, 2021
Outer membrane vesicle vaccines for Neisseria gonorrhoeaeEvgeny A Semchenko, Kate L Seib
Plos Genetics|October 27, 2009
The key role of genomics in modern vaccine and drug design for emerging infectious diseasesKate L Seib, Gordon Dougan, Rino Rappuoli
Cold Spring Harbor Perspectives in Medicine|May 3, 2013
Vaccines, reverse vaccinology, and bacterial pathogenesisIsabel Delany, Rino Rappuoli, Kate L Seib
Future Microbiology|February 15, 2018
Characterizing the meningococcal glycointeractome: what is new?Kate L Seib, Michael P Jennings, Christopher J Day
Vaccines|May 17, 2020
The <i>Neisseria gonorrhoeae</i> Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial CellsEvgeny A Semchenko, Christopher J Day, Kate L Seib
FEBS Letters|July 2, 2003
A Sco homologue plays a role in defence against oxidative stress in pathogenic NeisseriaKate L Seib, Michael P Jennings, Alastair G McEwan
Current Opinion in Infectious Diseases|March 31, 2018
Neisseria gonorrhoeae vaccine development: hope on the horizon?Jennifer L Edwards, Michael P Jennings, Kate L Seib
Infection and Immunity|November 30, 2016
MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking AntibodiesEvgeny A Semchenko, Christopher J Day, Kate L Seib
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|July 15, 2017
Gonorrhoea vaccines: a step in the right directionKate L Seib
Sexually Transmitted Infections|April 3, 2016
Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccineEvgeny A Semchenko, Kate L Seib
Nature Reviews. Urology|October 30, 2021
Outer membrane vesicle vaccines for Neisseria gonorrhoeaeEvgeny A Semchenko, Kate L Seib
Plos Genetics|October 27, 2009
The key role of genomics in modern vaccine and drug design for emerging infectious diseasesKate L Seib, Gordon Dougan, Rino Rappuoli
Cold Spring Harbor Perspectives in Medicine|May 3, 2013
Vaccines, reverse vaccinology, and bacterial pathogenesisIsabel Delany, Rino Rappuoli, Kate L Seib
Future Microbiology|February 15, 2018
Characterizing the meningococcal glycointeractome: what is new?Kate L Seib, Michael P Jennings, Christopher J Day
Vaccines|May 17, 2020
The <i>Neisseria gonorrhoeae</i> Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial CellsEvgeny A Semchenko, Christopher J Day, Kate L Seib
FEBS Letters|July 2, 2003
A Sco homologue plays a role in defence against oxidative stress in pathogenic NeisseriaKate L Seib, Michael P Jennings, Alastair G McEwan
Current Opinion in Infectious Diseases|March 31, 2018
Neisseria gonorrhoeae vaccine development: hope on the horizon?Jennifer L Edwards, Michael P Jennings, Kate L Seib
Infection and Immunity|November 30, 2016
MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking AntibodiesEvgeny A Semchenko, Christopher J Day, Kate L Seib
Pageof 11